Lausanne-based medical data specialists Sophia Genetics has appointed Ross Muken as chief financial officer. He joins from Click Therapeutics where he served as CFO and chief operating officer.
“I am delighted to welcome Ross to our team. His leadership and experience across the life science industry will be invaluable as we continue to advance our mission to develop and commercialise data analytics solutions,” said Jurgi Camblong, chief executive and founder of Sophia Genetics. “Ross is joining Sophia at an exciting time as the overall demand for data-driven medicine is rapidly growing. I look forward to his contributions as we enter into our next phase of growth.”
Before joining Click, he was partner, senior managing director and head of the healthcare services & technology research team at Evercore ISI where he covered more than 50 companies across the healthcare technology & distribution, life science tools & diagnostics, managed care & facilities and medical supplies & devices sub-sectors.
Before that, Muken was managing director at Deutsche Bank Securities and spent time in the equity research division of Thomas Weisel Partners. He began his career as an M&A investment banker at Bank of America Securities.